Turn Therapeutics
TTRX | NASDAQ
$8.55
-$0.79 (-8.51%)
At close: Nov 16, 2026, 4:00 PM ET
$8.48
-$0.07 (-0.82%)
After-hours:
Nov 16, 2026, 4:43 PM ET
-8.51%
(1D)Rating
22.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #976/1021 (Top 96%)
Key Statistics
Market Data
Market Cap $261.4M
1D Range
8.20 9.64
52W Range
2.71 15.34
Valuation (TTM)
PE -19.88
PB 45.92
EV/EBITDA -59.03
Valuation (NTM)
Forward PE N/A
Forward PEG -0.09
Price Target $9.00
Cash Flow
FCF Yield -2.0%
SBC Adj. FCF Yield -2.6%
SBC Impact -26.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -75.5% |
N/A
FCF 3Y | 5Y -71.2% |
N/A
Returns
ROA -78.1%
ROE -297.3%
ROIC -52.8%
Financial Health
Net Cash
$9.87M
Current Ratio 3.19
Interest Coverage -12.11
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The com...
Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Oct 8, 2025
Website www.turntherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$9.00
Upside
+5.26%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TTRX